References

No references inside the corpus for this window.

Cited by

• 2009Pharmacotherapy of PTSD: Premises, principles, and priorities153 cited
• 2008The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials140 cited
• 2008Validity of ‘post‐traumatic stress disorder with secondary psychotic features’: a review of the evidence128 cited
• 2003Linking Posttraumatic Stress Disorder and Psychosis127 cited
• 2021Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches126 cited
• 2018Posttraumatic stress disorder with secondary psychotic features (PTSD-SP): Diagnostic and treatment challenges125 cited
• 2010Psychopharmacologic Treatment of Posttraumatic Stress Disorder in Children and Adolescents116 cited
• 2004Treatment-Resistant Posttraumatic Stress Disorder: Strategies for Intervention109 cited
• 2004Current Concepts in Pharmacotherapy for Posttraumatic Stress Disorder107 cited
• 2006Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders102 cited
• 2009Guideline Watch (March 2009): Practice Guideline for the Treatment of Patients with Acute Stress Disorder and Posttraumatic Stress Disorder102 cited
• 2006Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women99 cited